EGFR and adenocarcinoma: Histologic transformation of NSCLC to SCLC has already been recognized as a crucial mechanism of acquired resistance to EGFR- or ALK-TKI in EGFR-mutated [48, 56] or ALK+ adenocarcinomas [57].